Is LEXX or LFCR more undervalued in 2026?

CirclFi compares Lexaria Bioscience Corp. (LEXX) and Lifecore Biomedical, Inc. (LFCR) using 13 institutional-grade valuation models. LEXX has a Quality of Company score of 6.7/10 while LFCR scores 4.9/10.

Which is a better buy — LEXX or LFCR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LEXX and LFCR valuations compare?

LEXX at $0.60 and LFCR at $5.02 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LEXX vs LFCR Valuation Comparison 2026 — Intrinsic Value Analysis

LEXX

Pharmaceutical Preparations

Lexaria Bioscience Corp.

Quality

6.7

out of 10

Value Trap

LOW

Price

$0.60

Last close

Models

11/13

Active

LFCR

Pharmaceutical Preparations

Lifecore Biomedical, Inc.

Quality

4.9

out of 10

Value Trap

SAFE

Price

$5.02

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	LEXX Fair Value	LEXX Upside	LFCR Fair Value	LFCR Upside
Bayesian DCF	Intrinsic	$0.27	-55.2%	—	—
Earnings Power Value	Intrinsic	$0.32	-54.5%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$0.25	-59.0%	$0.61	-86.0%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$0.57	-5.2%	$5.31	+5.7%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LEXX vs LFCR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LEXX vs LFCR — Which Stock Is More Undervalued?

LEXX scores higher with a 6.7/10 quality rating vs LFCR's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lexaria Bioscience Corp. (LEXX) and Lifecore Biomedical, Inc. (LFCR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LEXX currently trades at $0.60 with a QOC of 6.7/10, while LFCR trades at $5.02 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).